InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read MorePosted by Melanie Hamilton-Basich | Oct 20, 2020 | Covid 19, Mass Spectrometry |
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read MorePosted by Laurie Bonner | Oct 19, 2020 | Covid 19, Hematology & Serology |
The team tested alternative ways to measure covid-19 antibody levels, resulting in a process that is faster, easier, and less expensive to use on a large scale.
Read MorePosted by Laurie Bonner | Oct 16, 2020 | Covid 19, Molecular Diagnostics |
BioGX’s high-throughput RT-PCR test for covid-19 has been submitted for FDA EUA.
Read MorePosted by Laurie Bonner | Oct 16, 2020 | Covid 19, Diagnostic Technologies |
The method is able to differentiate with high accuracy SARS-CoV-2 from negative clinical samples as well as from other common respiratory pathogens.
Read MorePosted by Laurie Bonner | Oct 16, 2020 | Covid 19, Lab Management |
Labs that take longer than two days to complete these tests will receive a lower payment.
Read More